A phase II study of vinflunine in bladder cancer patients progressing after first-line platinum-containing regimen.

British Journal of Cancer
S CulineN James

Abstract

A multicentre phase II trial to determine the efficacy of vinflunine as second-line therapy in patients with advanced transitional cell carcinoma (TCC) of the bladder; secondary objectives were to assess duration of response, progression-free survival (PFS) and overall survival (OS), and to evaluate the toxicity associated with this treatment. Patients had tumours that failed or progressed after first-line platinum-containing regimens for advanced or metastatic disease, or had progressive disease after platinum-containing chemotherapy given with adjuvant or neoadjuvant intent. Response and adverse events were assessed according to WHO criteria and NCI-CTC (version 2), respectively. Out of 51 patients treated with 320 mg m(-2) of vinflunine, nine patients responded to the therapy yielding an overall response rate of 18% (95% CI: 8.4-30.9%), and 67% (95%CI: 52.1-79.3%) achieved disease control (PR+SD). Of note, responses were seen in patients with relatively poor prognostic factors such as a short (<12 months) interval from prior platinum therapy (19%, including an 11% response rate in those progressing <3 months after platinum treatment), prior treatment for metastatic disease (24%), prior treatment with vinca alkaloids (14%) an...Continue Reading

References

Jul 11, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P J LoehrerB A Lowe
Feb 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R S WitteP J Loehrer
May 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J A McCaffreyD F Bajorin
Nov 5, 1997·American Journal of Clinical Oncology·P PronzatoF Vaira
Nov 18, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W M StadlerF A Dorr
Dec 13, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J MooreN Murray
Apr 29, 1998·Cancer Chemotherapy and Pharmacology·A KruczynskiB T Hill
Dec 16, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·V LorussoM De Lena
Aug 17, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·B T HillA Kruczynski
Feb 13, 2002·Seminars in Oncology·Robert F Ozols
Feb 15, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David J VaughnAvi B Markowitz
Jul 3, 2002·Seminars in Oncology·Stephane Culine
Mar 22, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J BennounaM Marty
Jun 13, 2003·Lancet·UNKNOWN Advanced Bladder Cancer Meta-analysis Collaboration
Dec 11, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A BamiasUNKNOWN Hellenic Cooperative Oncology Group
Dec 2, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ramaprasad Srinivasan, W Marston Linehan
May 25, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C TheodoreP Fumoleau
Oct 8, 2005·Investigational New Drugs·Peter JohnsonIan Judson

❮ Previous
Next ❯

Citations

Apr 1, 2011·Clinical Investigation·Elizabeth A GuancialJonathan E Rosenberg
Oct 26, 2013·Future Oncology·Christina Ann Ortmann, Danish Mazhar
Aug 13, 2008·Journal of Hematology & Oncology·David Chu, Shenhong Wu
Oct 16, 2009·Investigational New Drugs·Hanna K SanoffE Claire Dees
Jan 30, 2010·Journal of Oncology·Ioannis A VoutsadakisChristos N Papandreou
Feb 13, 2009·Japanese Journal of Clinical Oncology·Takahito SuyamaMasayuki Maruoka
Oct 15, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J Bellmunt, M Guix
Feb 1, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J BellmuntJ E Rosenberg
Nov 30, 2010·Expert Review of Anticancer Therapy·Gopa IyerDean F Bajorin
Nov 26, 2011·Expert Review of Anticancer Therapy·Amy Q LeiChong-xian Pan
Dec 21, 2010·Expert Review of Anticancer Therapy·Ronac Mamtani, David J Vaughn
Dec 22, 2007·Expert Review of Anticancer Therapy·Guru SonpavdeThomas E Hutson
Jun 29, 2011·Expert Review of Anticancer Therapy·Evangelos BournakisAristotle Bamias
Dec 14, 2011·Expert Review of Anticancer Therapy·Carmel PezaroIan D Davis
Mar 28, 2008·Expert Opinion on Investigational Drugs·Adrian Yun-San YipLouis Wing-Cheong Chow
Apr 29, 2011·Expert Opinion on Drug Safety·Fabio A B SchutzToni K Choueiri
Nov 18, 2008·Expert Opinion on Investigational Drugs·Alexandros LekasAndreas C Lazaris
Jun 10, 2010·Expert Opinion on Investigational Drugs·Ioannis ZachosAthanasios G Papavassiliou
Jun 23, 2015·Expert Opinion on Investigational Drugs·Clarisse R Mazzola, Joseph Chin
Oct 22, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D RaggiA Necchi
Dec 12, 2007·BJU International·Chia-Chi LinNicholas J Vogelzang
Mar 18, 2016·Current Oncology Reports·Tracy L Rose, Matthew I Milowsky
Jun 30, 2010·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·John S Ng
Feb 18, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Guru SonpavdeNicholas J Vogelzang
Feb 10, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David J GallagherDean F Bajorin
Mar 17, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joaquim BellmuntJonathan E Rosenberg
Aug 19, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joaquim BellmuntHans von der Maase
Dec 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jorge A Garcia, Robert Dreicer
Oct 13, 2006·World Journal of Urology·Fabio Calabrò, Cora N Sternberg
Nov 28, 2008·BJU International·Guru Sonpavde, Cora N Sternberg
Nov 17, 2007·BJU International·Guru SonpavdeCora N Sternberg
Jan 4, 2017·Therapeutic Advances in Urology·Holger GerullisThorsten Holger Ecke
Feb 13, 2018·Expert Review of Anticancer Therapy·Michele MarchioniPierre I Karakiewicz
Feb 23, 2012·Urologia Internationalis·M RacioppiP F Bassi

❮ Previous
Next ❯

Methods Mentioned

BETA
xenografts

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.